Naruto Taira

2.4k total citations
144 papers, 1.5k citations indexed

About

Naruto Taira is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Naruto Taira has authored 144 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Oncology, 52 papers in Cancer Research and 50 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Naruto Taira's work include Breast Cancer Treatment Studies (50 papers), Cancer Treatment and Pharmacology (37 papers) and HER2/EGFR in Cancer Research (35 papers). Naruto Taira is often cited by papers focused on Breast Cancer Treatment Studies (50 papers), Cancer Treatment and Pharmacology (37 papers) and HER2/EGFR in Cancer Research (35 papers). Naruto Taira collaborates with scholars based in Japan, United States and Switzerland. Naruto Taira's co-authors include Hiroyoshi Doihara, Tadahiko Shien, Shozo Ohsumi, Kojiro Shimozuma, Tomohiro Nogami, Hirokuni Ikeda, Daisuke Takabatake, Fumikata Hara, Takayuki Iwamoto and Takeo Fujita and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Naruto Taira

136 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Naruto Taira Japan	23	796	436	400	338	204	144	1.5k
Laura Pizzuti Italy	23	906 1.1×	410 0.9×	454 1.1×	333 1.0×	140 0.7×	96	1.7k
Phuong K. Morrow United States	24	1.0k 1.3×	283 0.6×	525 1.3×	396 1.2×	181 0.9×	65	1.8k
Tadahiko Shien Japan	24	964 1.2×	767 1.8×	482 1.2×	468 1.4×	304 1.5×	164	1.8k
Kevin Kalinsky United States	25	1.1k 1.4×	506 1.2×	581 1.5×	558 1.7×	156 0.8×	107	1.9k
Massimiliano D’Aiuto Italy	22	563 0.7×	453 1.0×	449 1.1×	275 0.8×	162 0.8×	78	1.4k
Antonella Brunello Italy	23	907 1.1×	252 0.6×	354 0.9×	474 1.4×	138 0.7×	119	1.8k
Jacqueline M. Lafky United States	24	1.1k 1.4×	226 0.5×	385 1.0×	251 0.7×	162 0.8×	60	2.0k
Stephen Welch Canada	24	1.0k 1.3×	279 0.6×	626 1.6×	388 1.1×	244 1.2×	124	1.9k
Mary Cianfrocca United States	14	869 1.1×	533 1.2×	232 0.6×	239 0.7×	279 1.4×	31	1.3k
Soo Youn Bae South Korea	24	789 1.0×	824 1.9×	328 0.8×	283 0.8×	487 2.4×	92	1.7k

Countries citing papers authored by Naruto Taira

Since Specialization

Citations

This map shows the geographic impact of Naruto Taira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naruto Taira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naruto Taira more than expected).

Fields of papers citing papers by Naruto Taira

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naruto Taira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naruto Taira. The network helps show where Naruto Taira may publish in the future.

Co-authorship network of co-authors of Naruto Taira

This figure shows the co-authorship network connecting the top 25 collaborators of Naruto Taira. A scholar is included among the top collaborators of Naruto Taira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naruto Taira. Naruto Taira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamamoto, Yutaka, Chikako Yamauchi, Tatsuya Toyama, et al.. (2024). The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment. Breast Cancer. 31(3). 340–346. 2 indexed citations

Kikawa, Yuichiro, Yukari Uemura, Tetsuhiko Taira, et al.. (2024). A randomized study comparing electronic patient-reported outcome (ePRO) monitoring with routine follow-up during trastuzumab deruxtecan treatment in patients with metastatic breast cancer (PRO-DUCE study).. Journal of Clinical Oncology. 42(16_suppl). 1504–1504. 1 indexed citations

Takahashi, Masato, Yuichiro Kikawa, Kosuke Kashiwabara, et al.. (2024). Eribulin versus S-1 as first or second-line chemotherapy to assess health-related quality of life and overall survival in HER2-negative metastatic breast cancer (RESQ study): a non-inferiority, randomised, controlled, open-label, phase 3 trial. EClinicalMedicine. 74. 102715–102715. 3 indexed citations

Tanaka, Ryo, et al.. (2024). Radiation‑induced pleomorphic liposarcoma after hypofractionated radiotherapy following breast‑conserving surgery: A case report and literature review. Oncology Letters. 28(1). 325–325.

Taira, Naruto, Kosuke Kashiwabara, Junji Tsurutani, et al.. (2022). Association of Genetic Polymorphism with Taxane-induced Peripheral Neuropathy: Sub-analysis of a Randomized Phase II Study to Determine the Optimal Dose of 3-week Cycle Nab-Paclitaxel in Metastatic Breast Cancer Patients.. PubMed. 76(6). 661–671. 1 indexed citations

Yamanaka, T., Yuki Kataoka, Takeshi Yamaguchi, et al.. (2022). Efficacy of Telemedicine Using Videoconferencing Systems in Outpatient Care for Patients With Cancer: A Systematic Review and Meta-Analysis. JCO Clinical Cancer Informatics. 6(6). e2200084–e2200084. 11 indexed citations

Kawahara, Takuya, Takayuki Iwamoto, Kohei Uemura, et al.. (2022). Association of change in health-related quality of life and treatment discontinuation in metastatic breast cancer: a post hoc, exploratory analysis of two randomized clinical trials. Supportive Care in Cancer. 30(10). 8367–8375. 5 indexed citations

Takashima, Tsutomu, Fumikata Hara, Takayuki Iwamoto, et al.. (2021). A Correlation Analysis Between Metabolism-related Genes and Treatment Response to S-1 as First-line Chemotherapy for Metastatic Breast Cancer: The SELECT BC-EURECA Study. Clinical Breast Cancer. 21(5). 450–457. 1 indexed citations

Yamada, Akimitsu, Hiraku Kumamaru, Chikako Shimizu, et al.. (2021). Systemic therapy and prognosis of older patients with stage II/III breast cancer: A large-scale analysis of the Japanese Breast Cancer Registry. European Journal of Cancer. 154. 157–166. 9 indexed citations

10.

Sawaki, Masataka, Akimitsu Yamada, Hiraku Kumamaru, et al.. (2020). Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan. Breast Cancer. 28(1). 1–8. 11 indexed citations

11.

Murata, Tatsunori, Yoshimi Suzukamo, Takeru Shiroiwa, et al.. (2020). Response Shift–Adjusted Treatment Effect on Health-Related Quality of Life in a Randomized Controlled Trial of Taxane Versus S-1 for Metastatic Breast Cancer: Structural Equation Modeling. Value in Health. 23(6). 768–774. 6 indexed citations

12.

Takahashi, Yuko, Takayuki Iwamoto, Yoko Suzuki, et al.. (2019). Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer. Clinical Breast Cancer. 20(2). 117–124.e4. 3 indexed citations

13.

Tanaka, Takashi, T. Shawn Sato, Akio Tada, et al.. (2016). Prevalence and clinical significance of supra- or infraclavicular drainage on preoperative lymphoscintigraphy in women with breast cancer. Diagnostic and Interventional Imaging. 97(6). 611–615. 1 indexed citations

14.

Shien, Tadahiko, Takayuki Iwamoto, Tomohiro Nogami, et al.. (2015). Correlation between 18F-fluorodeoxyglucose Positron Emission Tomography/computed Tomography and Clinicopathological Features in Invasive Ductal Carcinoma of the Breast.. PubMed. 69(6). 333–8. 9 indexed citations

15.

Shien, Tadahiko, Takayuki Kinoshita, Kunihiko Seki, et al.. (2013). p53 expression in pretreatment specimen predicts response to neoadjuvant chemotherapy including anthracycline and taxane in patients with primary breast cancer.. PubMed. 67(3). 165–70. 4 indexed citations

16.

Hayashi, Tatsuro, Hiroaki Asano, Shinichi Toyooka, et al.. (2012). DNA methylation status of REIC/Dkk-3 gene in human malignancies. Journal of Cancer Research and Clinical Oncology. 138(5). 799–809. 25 indexed citations

17.

Sawaki, Masataka, Hirofumi Mukai, Nahomi Tokudome, et al.. (2011). Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study. Breast Cancer. 19(3). 253–258. 11 indexed citations

18.

Taira, Naruto, et al.. (2006). Gefitinib, an epidermal growth factor receptor blockade agent, shows additional or synergistic effects on the radiosensitivity of esophageal cancer cells in vitro.. PubMed. 60(1). 25–34. 22 indexed citations

19.

Takabatake, Daisuke, Takeo Fujita, Tadahiko Shien, et al.. (2006). Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR‐overexpressing breast cancer cell lines (MCF7/ADR, MDA‐MB‐231). International Journal of Cancer. 120(1). 181–188. 47 indexed citations

20.

Tsutani, Yasuhiro, Shozo Ohsumi, Kenjiro Aogi, et al.. (2006). A case of metastatic Breast Cancer with HER2 gene amplification that responded completely to single agent trastuzumab. Breast Cancer. 13(4). 374–377. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact